BioCryst Pharmaceuticals
IPOBioCryst® | A Pioneer in Rare Disease Therapeutics
Public · Durham, United States · Founded 1986
- Headquarters
- Durham, North Carolina
- Employees
- 201–500
- Founded
- 1986
- Business Model
- B2B
- Website
- biocryst.com
- Type
- Public
About
Rare disease biopharmaceutical company pioneering oral treatments for hereditary angioedema and other rare conditions.
Summary
BioCryst Pharmaceuticals is a Biotech company based in Durham, United States, founded in 1986. Investors include Royalty Pharma, OMERS Capital Markets and Athyrium Capital Management.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2021
Sign up to see all 3 rounds
IPO through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biocryst-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/biocryst-pharmaceuticals" alt="BioCryst Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>